Twenty to 40% of Guillain Barré syndrome (GBS) patients will not be able to walk independently despite effective treatment. Older patients carry additional risks for worse outcomes.
Methods:
A single center, ambispective cohort study was performed. Only subjects ≥18 years with a 3-month follow-up were included. Elderly patients were considered as a whole if ≥ 60 years. Demographics, CSF and nerve conduction studies were compared. A binomial logistic regression and Kaplan-Meier analyses were carried out to estimate good prognosis (Hugues ≤2) at 3-month follow-up.
Results:
From 130 patients recruited, 27.6% were elderly adults. They had a more severe disease, higher mEGOS and more cranial nerve involvement. Age ≥70 years, invasive mechanical ventilation and axonal subtype, portrayed an unfavorable 3-month outcome. Further analysis demonstrated an earlier recovery in independent walk at 3 months for patients <70 years.
Conclusions:
Elderly patients with GBS have a more severe disease at admission and encounter worse prognosis at 3-month follow-up, especially those above 70 years.
WuXLiCZhangB, et al.Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome. Crit Care. 2015;19(1):310. doi:10.1186/s13054-015-1037-z
2.
PericSBerisavacIStojiljkovic TamasO, et al.Guillain-Barré syndrome in the elderly. J Peripher Nerv Syst. 2016;21(2):105–110. doi:10.1111/jns.12163
3.
LeonhardSEMandarakasMRGondimFAA, et al.Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–683. doi:10.1038/s41582-019-0250-9
ZhangBWuXShenD, et al.The clinical characteristics and short-term prognosis in elderly patients with Guillain-Barre syndrome. Med (United States). 2017;96(1):e5848. doi:10.1097/MD.0000000000005848
6.
NagappaMRahulWSinhaS, et al.Guillain Barre Syndrome in the elderly: experience from a tertiary-care hospital in India. J Clin Neurosci. 2017;46:45–49. doi:10.1016/j.jocn.2017.08.048
7.
United Nations. Department of Economic and Social Affairs. Population Division. World Population 2017; 2017.
8.
VerdúECeballosDVilchesJJNavarroX. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5(4):191–208. doi:10.1046/j.1529-8027.2000.00026.x
9.
AsburyAKCornblathDR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(1S):S21–S24. doi:10.1002/ana.410270707
10.
RuudPKFransGMecheMPaulS. Interobserver agreement in the assessment of muscle strength Guillain-Barre syndrome. Muscle Nerv. 1991;14(11):1103–1109.
11.
HughesRACNewsom-DavisJMPerkinGDPierceJM. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;312(8093):750–753. doi:10.1016/S0140-6736(78)92644-2
12.
WalgaardCLingsmaHFRutsLVan DoornPASteyerbergEWJacobsBC. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology. 2011;76(11):968–975. doi:10.1212/WNL.0b013e3182104407
WakerleyBRUnciniAYukiN. Guillain-Barré and Miller Fisher Syndromes—New diagnostic classification. Nat Rev Neurol. 2014;10(9):537–544. doi:10.1038/nrneurol.2014.138
15.
HaddenRDMCornblathDRHughesRAC, et al.Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–788. doi:10.1002/ana.410440512
16.
DoetsAYVerboonCvan den BergB, et al.Regional variation of Guillain-Barre syndrome. Brain. 2018;141(10):2866–2877. doi:10.1093/brain/awy232
17.
KatzSFordABMoskowitzRWJacksonBAJaffeMW. Studies of illness in the aged the index of ADL: a standardized measure of biological and psychosocial function downloaded from: by a university of Adelaide library user on 10/08/2017 table 1.—index of independence in activities of daily living. JAMA. 1963;185(12):914–919.
18.
CollinsGSReitsmaJBAltmanDGMoonsKGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement. BMC Med. 2015;13(1):1–10. doi:10.1186/s12916-014-0241-z
19.
INEGI. Perfil Sociodemográfico de Adultos Mayores. Vol 1; 2014.
20.
SejvarJJBaughmanALWiseMMorganOW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–133. doi:10.1159/000324710
21.
OECD/The World Bank. Health at a Glance: Latin America and the Caribbean 2020. OECD Publishing; 2020. doi:10.1787/6089164f-en
22.
WebbAJSBrainSAEWoodRRinaldiSTurnerMR. Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry. 2015;86(11):1196–1201. doi:10.1136/jnnp-2014-309056
23.
López-HernándezJCColunga-LozanoLEGarcia-TrejoS, et al.Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barré syndrome, a single center experience. J Clin Neurosci. 2020;80:292–297. doi:10.1016/j.jocn.2020.04.059
24.
Van Den BergBWalgaardCDrenthenJFokkeCJacobsBCVan DoornPA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–482. doi:10.1038/nrneurol.2014.121
25.
Domínguez-morenoRTolosa-tortPPatiño-tamezA, et al.Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol. 2014;58(1):4–10. doi:10.33588/rn.5801.2013370
CornblathDRMellitsEDGriffinJW, et al.Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol. 1988;23(4):354–359. doi:10.1002/ana.410230407
MeskersCGMReijnierseEMNumansST, et al.Association of handgrip strength and muscle mass with dependency in (instrumental) activities of daily living in hospitalized older adults—the empower study. J Nutr Heal Aging. 2019;23(3):232–238. doi:10.1007/s12603-019-1170-5
30.
GuralnikJMFerrucciLBalfourJLVolpatoSDi IorioA. Progressive versus catastrophic loss of the ability to walk: implications for the prevention of mobility loss. J Am Geriatr Soc. 2001;49(11):1463–1470. doi:10.1046/j.1532-5415.2001.4911238.x
